Community/Retail

Health systems cannot afford to do without these pharmacies in their hospitals.

Acute otits media is a very common and painful occurrence in our pediatric patients.

How many times have we second guessed our abilities, down played our efforts, or not taken risks to move your career forward? Here are three tips to enable you to learn to bet on yourself.

With the growth in pharmacy over the past 10 years, pharmacists are now at the forefront of managing many more disease states than in the past.

This article highlights several key therapeutics areas with Sublocade that every pharmacist should know.

Flu prevention education is a great opportunity for pharmacists to change misconceptions.

With 2017 behind us, we’re looking ahead at the next year for what’s on the horizon in pharmacy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Here are some ways to have a great start in our pharmacies.

It is possible to lose weight more quickly eating the same number of calories, just by getting into the right metabolic position.

Have a plan to minimize stress and reduce post-party guilt.

The FDA has permitted marketing of a new device intended to treat diabetic foot ulcers.

A look at some of the top read articles on Pharmacy Times from 2017.

Busy pharmacists looking to achieve their health goals for 2018 should look no further than their cell phones.

With the New Year on our heels, let’s look back on some of the most noteworthy FDA approvals of 2017.

Why I included a computer coding aspect into my APPE rotation

What my experience in pharmacy, jazz piano and language studies have in common

Make a commitment to make the workplace a cleaner, happier, and healthier place in 2018.

Abbott has released its newest system for type 1 and 2 diabetes.

This is the first part of a series on how pharmacy professionals have been depicted on TV, both in a positive and negative manner.

When people hear the word cholesterol, they typically think of a fatty, plaque-building substance that comes from the foods we eat.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Hydroxyurea is indicated to decrease the prevalence of painful crises and the need for transfusions in pediatric patients aged 2 years and older with sickle cell anemia with moderate-to-severe painful crises.

The FDA recently approved nivolumab (Opdivo) for the treatment of patients with melanoma whose disease has spread to the lymph nodes or those with metastatic disease who have undergone resection, according to a press release.

Officials with the FDA recently approved cabozantinib (Cabometyx) for the first-line treatment of patients with advanced renal cell carcinoma (RCC), according to a press release.

Officials with the FDA granted accelerated approval to bosutinib (Bosulif) for the treatment of patients with newly-diagnosed chronic phase (CP) Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).

Now that Eli Lilly is looking to create a closed-loop system for diabetes management, does that mean this product will soon be available?

Negative interactions with doctors' offices can have serious consequences, so play nice.

We explore what happened and talk to CVS corporate to get their take.

Officials with the FDA have approved angiotensin II (Giapreza, La Jolla Pharmaceutical Company) injection for intravenous infusion to treat dangerously low blood pressure in adults with septic or other distributive shock.